Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2003
11/27/2003WO2003097645A1 5-ethylimidarotriazones
11/27/2003WO2003097644A2 Non-nucleoside reverse transcriptase inhibitors
11/27/2003WO2003097642A1 Anti-tumour polycyclic carboxamides
11/27/2003WO2003097641A2 1h-imidazo[4,5-c] quinoline derivatives in the treatment of protein kinase dependent diseases
11/27/2003WO2003097639A1 Benzoxazine and benzoxazinone substituted triazoles
11/27/2003WO2003097638A1 (s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofurylcarbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
11/27/2003WO2003097637A1 (imidazol-1-yl-methyl)-pyridazine as nmda receptor blocker
11/27/2003WO2003097636A1 Novel compounds and their use
11/27/2003WO2003097635A1 Processes for preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3h-[ring fused indol-5-yl(amine-derived)] compounds and analogues thereof, and to products obtained therefrom
11/27/2003WO2003097633A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics
11/27/2003WO2003097631A1 Radiosensitizer composition containing n-acetylphytosphingosine analogs and n,n-dimethyl-phytosphingosine analogs as the active ingredients
11/27/2003WO2003097626A1 Manufacture of ascorbic acid esters
11/27/2003WO2003097625A1 Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use
11/27/2003WO2003097623A1 Aralkyl-ketone piperazine derivatives and their uses as new antalgic or ataractic agent
11/27/2003WO2003097622A2 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof
11/27/2003WO2003097621A1 Methods of using thiazolidinedithione derivatives
11/27/2003WO2003097620A1 Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same
11/27/2003WO2003097619A1 Glucagon antagonists/inverse agonists
11/27/2003WO2003097617A1 Cysteine protease inhibitors
11/27/2003WO2003097616A1 Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
11/27/2003WO2003097615A1 TREATMENT OF FIBROPROLIFERATIVE DISORDERS USING TGF-β INHIBITORS
11/27/2003WO2003097613A1 Pyridazin-3(2h)-one derivatives as pde4 inhibitors
11/27/2003WO2003097611A1 Novel imidazole compounds, method for preparing same and use thereof as medicines
11/27/2003WO2003097610A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/27/2003WO2003097608A2 Opioid and opioid-like compounds and uses thereof
11/27/2003WO2003097605A1 Pesticidal pyridinecarboxamide derivatives
11/27/2003WO2003097604A1 Pyridine carboxamide derivatives and their use as pesticides
11/27/2003WO2003097602A1 Cyanoguanidine produgs
11/27/2003WO2003097601A1 Cyanoguanidine prodrugs
11/27/2003WO2003097598A1 Compound exhibiting pgd 2 receptor antagonism
11/27/2003WO2003097597A2 Indole derivatives and the use thereof as cb2 receptor ligands
11/27/2003WO2003097596A1 8-azaprostaglandin analogs as agents for lowering intraocular pressure
11/27/2003WO2003097595A1 Lactams used as anti-viral agents
11/27/2003WO2003097593A2 Protease inhibitors
11/27/2003WO2003097592A2 Treatment of age-related lung abnormalities using estrogen and/or retinoids
11/27/2003WO2003097591A1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
11/27/2003WO2003097586A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003WO2003097585A2 Amidoacetonitrile compounds
11/27/2003WO2003097582A2 Synthesis of benzonitriles and benzimidates
11/27/2003WO2003097573A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
11/27/2003WO2003097564A2 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
11/27/2003WO2003097356A1 Camptothecin derivatives and polymeric conjugates thereof
11/27/2003WO2003097164A1 Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
11/27/2003WO2003097163A2 Using a selective inos inhibitor for the treatment of respiratory diseases and conditions
11/27/2003WO2003097140A1 Drug delivery assembly
11/27/2003WO2003097110A1 Therapeutic target and uses thereof
11/27/2003WO2003097107A2 Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
11/27/2003WO2003097104A1 Treatment and prevention of tissue damage
11/27/2003WO2003097102A1 Pharmaceutical preparation improved in dissolving property of drug slightly soluble in water
11/27/2003WO2003097101A1 Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity
11/27/2003WO2003097100A1 Topical composition for the treatment of inflammatory conditions of the skin
11/27/2003WO2003097099A1 Combination of angiotensin ii receptor blocker and beta-blocker for secondary prevention of myocardial infarction
11/27/2003WO2003097098A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
11/27/2003WO2003097095A1 Process for the preparation and activation of substances and a means of producing same
11/27/2003WO2003097091A2 Glucan-based vaccines
11/27/2003WO2003097078A1 Nutraceutical compositions comprising citrus alkaloids and method
11/27/2003WO2003097076A1 Herbal formulations against adenocarcinoma of the prostate
11/27/2003WO2003097073A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
11/27/2003WO2003097072A1 Chloasma amelioration composition and dullness amelioration composition
11/27/2003WO2003097071A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
11/27/2003WO2003097070A1 The pharmaceutical composition comprising a corticosteroid and an antiseptic
11/27/2003WO2003097069A1 Trimegestone and estrogens for treating post menopausal disorders
11/27/2003WO2003097068A1 Use of peroxovanadium compounds as tumour cell growth suppressor
11/27/2003WO2003097067A1 Combination of an ace inhibitor, a calcium channel blocker and a diuretic
11/27/2003WO2003097066A1 Use of meloxicam for alleviating organ injury during organ operation or transplantation
11/27/2003WO2003097065A1 5-ht4 receptor antagonists for the treatment of heart failure
11/27/2003WO2003097064A1 Therapeutic agent for diabetes
11/27/2003WO2003097063A1 Derivatives of 2-(1-benzyl-1h-pyrazolo (3, 4-b)pyridine-3yl) -5-(4-pyridinyl)-4-pyrimidine amine and the use thereof as guanylate cyclase stimulators
11/27/2003WO2003097062A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles
11/27/2003WO2003097061A1 External preparation for allergic diseases
11/27/2003WO2003097060A1 Oral therapeutic or preventive drugs for pollakiuria and urinary incontinence or oral sleep inducers, containing tropolone derivatives
11/27/2003WO2003097059A1 Polymorphic forms of phenyl oxazolidinone derivatives
11/27/2003WO2003097058A1 New pharmaceutical compositions containing flibanserin polymorph a
11/27/2003WO2003097057A1 Synergistic combination of an opioid analgesic and a nsaid
11/27/2003WO2003097056A1 Pyrroloquinoline quinone for treatment of cardiac injury and methods of use thereof
11/27/2003WO2003097055A2 Inhibitors of resistance to bacteria antibiotics
11/27/2003WO2003097054A1 Compositions and method for treating infection in cattle and swine
11/27/2003WO2003097053A1 Compounds, compositions, and methods
11/27/2003WO2003097052A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
11/27/2003WO2003097051A2 Use of compounds that are effective as selective opiate receptor modulators
11/27/2003WO2003097050A2 A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
11/27/2003WO2003097049A1 Anti-estrogen receptor agents for chemotherapy and prevention
11/27/2003WO2003097048A1 Diaminothiazoles
11/27/2003WO2003097047A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003WO2003097046A1 Method for treating obesity
11/27/2003WO2003097045A1 Combination of organic compounds
11/27/2003WO2003097044A1 Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia
11/27/2003WO2003097043A1 Treatment of neuropathic pain
11/27/2003WO2003097042A1 Pgd2 receptor antagonist
11/27/2003WO2003097041A1 Annelated pyrrole compounds as proton pump inhibitors for treating ulcer
11/27/2003WO2003097040A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
11/27/2003WO2003097038A1 Method for treating dermatoses and tissue damage
11/27/2003WO2003097037A1 Allergic symptom reliever
11/27/2003WO2003097036A1 N-acylaminoacetonitrile derivatives and their use for controlling parasites
11/27/2003WO2003097035A1 Non-steroidal anti-androgen therapy
11/27/2003WO2003097034A1 TGF-α EXPRESSION INHIBITORS
11/27/2003WO2003097032A1 Means for weaning people off smoking and alcohol
11/27/2003WO2003097031A1 Obesity preventive or ameliorator containing methylidene hydrazide compound as active ingredient
11/27/2003WO2003097030A1 Use of 4-(4'-aminophenylsulphonyl)-benzoic acid and esters thereof as anti-inflammatory agents
11/27/2003WO2003097029A1 Methods of treating gastrointestinal and genitourinary pain disorders using vinlafaxin and derivatives
1 ... 5259 5260 5261 5262 5263 5264 5265 5266 5267 5268 5269 5270 5271 5272 5273 5274 5275 5276 5277 5278 5279 ... 7860